Acetohydroxamic acid therapy in infected renal stones.
The use of acetohydroxamic acid at different dosages is recommended in the treatment of renal lithiasis secondary to urease-producing bacteria. The effects of this drug are directed to urinary ammonium and urinary pH reduction and to potentiation of antibiotic therapy.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007668:Kidney / Q000378:metabolism; D007669:Kidney Calculi / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D000644:Quaternary Ammonium Compounds / Q000652:urine; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D006877:Hydroxamic Acids; D000644:Quaternary Ammonium Compounds; C006358:acetohydroxamic acid